tiprankstipranks
Trending News
More News >

Howard Robin Insider Profile

11 Followers
Howard Robin, President & CEO, Director at Nektar Therapeutics, holds 49.37K shares in Nektar Therapeutics (Ticker: NKTR).
tipranks
Howard Robin

Howard Robin
Nektar Therapeutics (NKTR)
President & CEO, Director

Ranked #101,882 out of 103,781 Corporate Insiders

Profitable Transactions

17%
3 out of 18 Profitable Transactions

Average Return

-132.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
100.00%
A breakdown of Howard Robin's holdings

Insider Roles

Nektar Therapeutics
(NKTR)
President & CEO, Director
Roles that Howard Robin holds in companies

Most Profitable Insider Trade

Stock:
Nektar Therapeutics
(NKTR)
Rating:Informative Sell
Date:Nov 18, 2022 - Nov 18, 2023
Return:+86.20%
The most profitable trade made by Howard Robin

Howard Robin's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Nektar Therapeutics
Sep 11, 2025
President & CEO, Director
Uninformative Sell
311.21K
$2.79M
Success Rate for
NKTR
3 out of 18 profitable transactions on
NKTR
17%
Average Return for
NKTR
Average return per transaction on
NKTR
-132.89%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jul 18, 2016
Uninformative Buy
$0.00
-
$0.00
Dec 15, 2016
Uninformative Buy
$0.00
-
$0.00
Nov 17, 2017
Uninformative Buy
$0.00
-
$0.00
Dec 19, 2017
Uninformative Buy
$0.00
-
$0.00
Aug 16, 2018
Uninformative Buy
$427.60K
-
$10.69
List of latest transactions for each holding click on a transaction to see Howard Robin's performance on stock

Howard Robin insider profile FAQ

What is the percentage of profitable transactions made by Howard Robin?
The percentage of profitable transactions made by Howard Robin is 17%.
    What is the average return per transaction made by Howard Robin?
    The average return per transaction made by Howard Robin is -132.80%.
      What stocks does Howard Robin hold?
      Howard Robin holds: NKTR stocks.
        What was Howard Robin’s latest transaction?
        Howard Robin latest transaction was an Uninformative Sell of $311.21K.
          What was Howard Robin's most profitable transaction?
          Howard Robin’s most profitable transaction was an Informative Sell of NKTR stock on November 18, 2022. The return on the trade was 86.20%.
            What is Howard Robin's role in Nektar Therapeutics?
            Howard Robin's role in Nektar Therapeutics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.